At the Annual Meeting of Stockholders of ImmunoCellular Therapeutics, Ltd. (the "Company") held on August 24, 2012, the Company's stockholders voted on (i) the election of five directors (Proposal I), and (ii) the ratification of the appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2012 (Proposal II). The results of the votes are set forth below:

Proposal I - The stockholders voted in favor of the election of each of the five nominated individuals to serve as directors until the 2013 Annual Meeting of Stockholders and until their successors are duly elected and qualified as follows:

     Nominee                 Votes For        Votes Withheld       Broker Non-Votes
     Richard Chin, M.D.       10,369,251              331,590             22,255,231
     Richard A. Cowell         9,618,065            1,082,776             22,255,231
     Helen S. Kim             10,339,253              361,588             22,255,231
     Rahul Singhvi, Sc.D.      9,538,505            1,162,336             22,255,231
     John Yu, M.D.            10,445,430              255,411             22,255,231

Proposal II - The stockholders voted in favor of the ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2012 as follows:

Votes For Votes Against Abstain 30,962,917 1,735,935 257,220